Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline vs tigecycline for CRKP infections
ChiCTR2500098643Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of eravacycline and tigecycline in Intra-abdominal infection (IAI), bloodstream infection (BSI), pulmonary infection and 2 more (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: All-cause mortality at day 14 (primary). Planned start Mar 2025; status: not yet recruiting.
02
Drugs
eravacyclinetigecycline
03
Conditions
Intra-abdominal infection (IAI)bloodstream infection (BSI)pulmonary infectionurinary tract infection (UTI)Klebsiella pneumoniae infection
Beyond the preview
Go deeper on ChiCTR2500098643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098643.